Clinical Trials Directory

Trials / Completed

CompletedNCT02672137

Knowledge Translation for Patients With Acute Coronary Syndromes

Knowledge Translation to Promote Evidence-based Medical Therapy in Acute Coronary Syndromes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4,604 (actual)
Sponsor
Montreal General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Cluster randomized open-label experimental study multi-center of 24 hospitals to either knowledge translation vs usual care to improve care of patents hospitalized for acute coronary syndromes.

Detailed description

The AMI-OPTIMA study was a cluster randomized controlled trial of 24 hospitals to one-year knowledge translation (KT) vs usual care. Prior to randomization, we reviewed charts of 100 consecutive acute coronary syndromes (ACS) patients at each participating hospital in 2009. During one year, hospitals randomized to KT completed: 1) revision of the most recent American Heart Association Guidelines of ACS management, 2) focus groups to identify and solve local care gaps, and 3)local champion team to promote evidence-based medical therapy (EBMT). At the end of 12-month of KT/usual care, we reviewed discharge prescriptions of 100 consecutive ACS patients at each participating hospital (year 2012). EBMT was pre-defined as in-hospital anticoagulation and discharge prescription of dual anti-platelets, beta-blockers, statins, and angiotensin pathway modulating agents (for patients with impaired left ventricular systolic function). Refusal, impaired cognitive function, allergy or intolerance of patients to any of EBMT were considered valid reasons for withholding EBMT.

Conditions

Interventions

TypeNameDescription
BEHAVIORALknowledge translationknowledge translation that include: Community of practice, local gap analysis, opinion leaders, targeted interventions, performance feedback, reminders and local formation of ACS teams.

Timeline

Start date
2010-01-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2016-02-03
Last updated
2016-02-03

Source: ClinicalTrials.gov record NCT02672137. Inclusion in this directory is not an endorsement.